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VKORC1 sequence variants 
associated with resistance to 
anticoagulant rodenticides in Irish 
populations of Rattus norvegicus 
and Mus musculus domesticus
Jean Mooney1, Mark R. Lynch2, Colin V. Prescott3, Tracy Clegg4, Michael Loughlin5, Bernard 
Hannon6, Colm Moore7 & Richard Faulkner7
While resistance to anticoagulant rodenticides is known to occur in many European populations 
of Norway rat and house mouse, to-date no data is available on the occurrence in Ireland of such 
resistance. No genetic evidence for the occurrence of resistance was found in 65 Norway rat samples 
analysed, indicative of an absence, or low prevalence, of resistance in rats in at least the Eastern region 
of the island of Ireland. The presence of two of the most commonly found amino acid substitutions 
Leu128Ser and Tyr139Cys associated with house mouse resistance to anticoagulant rodenticides 
was confirmed. The occurrence of two such mutations is indicative of the occurrence of resistance to 
anticoagulant rodenticides in house mice in the Eastern region of the island of Ireland.
Following their introduction in the 1950s, warfarin and the structurally similar anticoagulant rodenticides (e.g. 
chlorophacinone and coumatetralyl), resulted in radical changes in rodent pest management practice. The newly 
introduced rodenticides had delayed action, with the result that mortality followed days or weeks after initiation 
of treatment, an effect that rendered them especially suitable for use to control Norway rats, also known as brown 
rats (Rattus norvegicus), a species that displays neophobic reactions. Reflecting the higher tolerance of house mice 
(Mus musculus) to such compounds, the use of warfarin and other first generation anticoagulants for their control 
was frequently unsatisfactory1.
Following the identification in 1958 of warfarin resistant rat populations in Scotland2, such resistance was sub-
sequently confirmed at locations in Wales, in England3, in Denmark4, in Germany5, in Belgium6 and is now con-
sidered widespread. The first reports of warfarin-resistant mice populations were published in the early 1960s7.
As a consequence of increasing concerns generated by the identification of warfarin resistant rodent popula-
tions, industry developed the more potent anticoagulant rodenticides bromadiolone, brodifacoum, difenacoum, 
difethialone and flocoumafen, known as second generation anticoagulant rodenticides. As in the case of the 
first-generation compounds, these reflect the 4-hydroxycoumarin structure, but display increased lipophilicity 
that results in their having longer half-lives8.
Anticoagulant rodenticides being vitamin K antagonists, block Vitamin K metabolism in the liver by prevent-
ing the enzyme vitamin K epoxide reductase (VKOR) from reducing vitamin K epoxide to vitamin K. Vitamin 
K, an essential co-factor for the activation of a number of vitamin K-dependant coagulation factors, plays an 
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important role in blood coagulation9. As a consequence of anticoagulant binding with VKOR, a deficiency of 
vitamin K and coagulation factors occur, resulting in spontaneous bleeding and eventual death.
In populations of resistant rats, VKOR is slightly changed thus preventing correct binding with the rodenticide 
which then fails to work10, a mechanism based on single nucleotide polymorphisms (SNPs) in the VKORC1 gene 
that codes for the VKOR enzyme11. The VKOR1 gene which has 6126 base pairs and three exons, codes for the 
VKOR1 protein that contains 163 amino acids12. Specific amino acid substitutions in VKORC1 have been shown 
to confer resistance to anticoagulant rodenticides and are considered to be a prerequisite for the development 
of rodenticide-resistant populations of rats and mice. Independent mutation events appear to have caused the 
emergence of resistant populations in different areas, affecting certain amino acid positions of the VKORC1 
protein13,14. It has been suggested that at least seven independent polymorphisms occur in the VKORC1 gene in 
Norway rats that provide the genetic basis for anticoagulant resistance in that species, while at least two occur in 
house mice, although the mutations identified do not explain all aspects of resistance that have been reported13.
Scientists in Denmark, Germany and the UK that monitored the evolution and distribution of resistance3,4,15, 
observed that resistance expanded geographically and progressed from warfarin to the more potent active 
substances bromadiolone and difenacoum. Resistance to brodifacoum has also been reported16. Resistance to 
different anticoagulant rodenticides is known as cross-resistance and evolves from first- to second-generation 
anticoagulants5. As a consequence, resistance to second-generation anticoagulant rodenticides will always be 
accompanied by resistance to first-generation compounds.
While there have been anecdotal reports of the occurrence of resistance in rodent pest populations in Ireland, 
to-date there has been no scientific investigation of the matter. The current study was intended to establish if 
genetic evidence of resistance to anticoagulant rodenticides is present in rodent pest populations on the island of 
Ireland and if possible to establish the geographical distribution of such populations.
Materials and Methods
Whole carcases or tail segments of 65 Norway rats and tails of 50 house mice taken between October 2015 and 
February 2017, were provided by professional pest control officers working in the eastern region of the island of 
Ireland. The sites from which the samples were provided were distributed throughout the region (Figs 1 and 2). 
The number of samples provided was considerably less than had been planned and resulted in the project being 
terminated following the sampling of the eastern region of Ireland. Nevertheless as rodent pests are commensal 
and as the population of the counties in which sampling took place contain approximately 51% of the population 
of Ireland in the case of Norway rats and 43% in the case of house mice17, the areas sampled provide a satisfactory 
representation of a large part of the island of Ireland.
Figure 1. Distribution of Norway Rat Sample Sites. More than one sample was taken at some locations: Green 
indicators show the locations of sampling some 65 rats, none of which had mutations associated with resistance 
to anticoagulant rodenticides.
www.nature.com/scientificreports/
3SCIENTIFIC RepoRts |  (2018) 8:4535  | DOI:10.1038/s41598-018-22815-7
On receipt in the laboratory, samples were logged in and stored at −80 °C pending analysis.
Rat tail tissue was excised from tail bone using a scalpel and a fragment of tissue was shaved from the internal 
membrane of the tail. Mice tails were finely chopped with a scalpel. The tissue fragments were added to 800 µl MagNa 
Pure Total Nucleic Acid Isolation Kit lysis buffer (Roche Diagnostics Cat No. 03038505001) and 20 µL Proteinase K 
@ 20 mg/mL (Sigma Cat No. P2308) and digested at 55 °C for 8–24 hours. Total Nucleic acid was extracted from the 
supernatant on a MagNA Pure LC automated extraction instrument using MagNa Pure Total Nucleic Acid Isolation 
Kit (Roche Diagnostics Cat No. 03038505001) in accordance with the manufacturer’s instructions. The quality of the 
extracted nucleic acid was evaluated by testing all extracts for the reference gene ß-actin.
The three exons of the rat VKORC1 gene were amplified by PCR using primers listed in Table 1. The primer 
sequences for the mouse VKORC1 exons were received from S. Rost, Institut für Humangenetik, Würzburg 
and were referenced in14. PCR reactions on the extracted rat samples were performed with Accustart II PCR 
ToughMix (Quanta Biosciences Cat. No. 95142-800) at 94 °C for 3 min followed by 40 cycles of 30 sec at 94 °C, 
30 sec at 60 °C and 1 min at 72 °C and a final 10 minutes at 72 °C. For the mouse samples the annealing temper-
ature was reduced to 57 °C. The PCR products were cleaned with Illustra ExProStar 1-step Enzymatic PCR and 
Sequence Reaction Clean-up Kit (GE Healthcare Life Sciences Cat No. US77720), according to the manufacturer’s 
instructions. The treated extracts were quantified by Qubit prior to sequencing.
Sanger sequencing of the extracts, provided by the Molecular Virology Laboratory of the Department of 
Agriculture, Food and the Marine was conducted by the contract laboratory Source BioScience18.
Results and Discussion
Sixty five Norway rat samples (Fig. 1) and fifty house mouse samples (Fig. 2) were successfully extracted and 
sequenced for all three exons (Tables 2 and 3). The rat sequences were aligned with the NCBI Rattus norvegicus 
VKORC1 reference sequence (NM_203335.2). The mice sequences were aligned with the NCBI Mus musculus 
VKORC1 reference sequence (NM_178600.2). The sequence trace files were visually analysed for the presence of 
mutations in the three exons when compared with the reference sequences.
Rattus novegivcus. There were no polymorphisms (95% CI: 0.00% to 5.58%) in exons 1 and 3 of the rat sam-
ples when compared with the Rattus norvegicus VKORC1 reference strain (NM_203335.2). A single nucleotide 
Figure 2. Distribution of House Mouse Sample Sites. More than one sample was taken at some locations: 
Yellow indicators show the locations of sampling 7 mice with a mutation on Exon 3, Codon 128, homozygous 
Leu128ser L128s, a mutation associated with resistance to warfarin and in some cases to bromadiolone 
and difenacoum. Red indicators show the locations of sampling 7 mice with a mutation on Exon 3, Codon 
139, homozygous Tyr139Cys Y139c, a mutation indicative of a high degree of resistance to warfarin and 
bromadiolone. Green indicators show the locations of sampling 28 mice that had heterozygous mutations 
associated with resistance to anticoagulant rodenticides and 8 that did not have any mutations.
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polymorphism (SNP) was observed in codon 82 of exon 2. This point mutation, Ile82Ile, did not result in an 
amino acid substitution. Fourteen (21.5%, 95% CI: 12.3% to 33.5%) were heterozygous for the point mutation 
and 7 (11%, 95% CI: 4.4% to 20.9%) were homozygous. The silent mutation Ile82Ile has been detected in Rattus 
norvegicus in England, Europe, Indonesia, Korea, the Azores and North and South America at a high frequency14. 
There is no evidence to date that the silent mutation Il82Il is implicated in anticoagulant resistance, however it has 
been suggested that the mutation may alter the efficiency of translation of the VKORC1 gene and therefore alter 
the biological response to anticoagulant exposure19.
Rats with the Tyr139Cys, Tyr139Ser and Leu128Gln substitutions in the VKORC1 gene have been found 
throughout Germany and Switzerland. These mutations are known to confer resistance to anticoagulants or to 
reduce VKOR activity13. Warfarin resistant rats have been shown to be both heterozygous and homozygous for the 
mutation Tyr139Cys11. In Kent the substitution Tyr139Phe was also found in resistant Norway rats at a site treated 
with bromadiolone bait. All rats tested from the Kent site were found to be homozygous for the mutation19.
Primer Sequence 5′-3′ Accession No. and Co-ordinates Reference*
RE1AF CTCTTGTGTCTGCGCTGTAC FQ210919 D. Rymer
RE1R GCTTTTCATTTCTGCACGCA HM181985.1 248-229 D. Rymer
RE2CF GGGTGGCGCTTCTTGCTAA HM181985.1 942–960 NCBI – Primer BLAST
RE2BR ACTCCTGCTAAGTGTTCTCCTTG HM181985.1 1280-1260 NCBI – Primer BLAST
RE3F TGAGTTCCCTGGTGTCTGTC HM181985.1 2031-2050 D. Rymer
RE3R TTTTAGGGACCCACACACGA HM181985.1 2280-2261 D. Rymer
Table 1. Primer sequences for the PCR amplification of the three exons of the VKORC1 gene in rat samples. 
*The rat primer sequences for Exon 1 and 3 were received from D.Rymer, School of Biological Sciences, The 
University of Reading. Rat exon 2 primers were designed using NCBI primer-BLAST on the Rattus rattus 
frugivorus Vkorc1 gene HM181985.1.
County
Sample Numbers 
Analysed Mutations found
Antrim 1 0
Carlow 1 0
Dublin 34 0
Kildare 4 0
Kilkenny 11 0
Longford 1 0
Meath 3 0
Offaly 2 0
Waterford 2 0
Wexford 3 0
Wicklow 3 0
Totals 65 0
95% Confidence Interval 0.00–5.58%
Table 2. Observed Occurrence by County of Mutations associated with Anticoagulant Resistance in Norway 
Rats.
County
Sample Numbers 
Analysed
Mutation leu128ser L128S (warfarin, 
bromodialone & difenacoum)
Mutation Tyr139Cys Y139C 
(warfarin & bromadiolone)
Heterozygous Homozygous Heterozygous Homozygous
Dublin 23 9 5 8 3
Kildare 10 4 0 2 0
Meath 7 4 1 5 4
Tipperary 1 1 0 1 0
Wexford 9 4 1 0 0
Totals 50 22 (44%) 7 (14%) 16 (32%) 7 (14%)
95% Confidence Intervals 30.0–58.7% 5.8–26.7% 19.5–46.7% 5.8–26.7%
Table 3. Observed Occurrence by County of Mutations associated with Anticoagulant Resistance in House 
Mice.
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Mutations associated with resistance to anticoagulant rodenticides have not been detected in Norway rats in 
this study, indicative of an absence, or low prevalence of genetic evidence of resistance to anticoagulant rodenti-
cides in Norway rats in at least the Eastern region of the island of Ireland.
Mus musculus domesticus. Leu128Ser and Tyr139Cys are the most frequent amino acid substitutions 
that have been found to occur in the VKORC1 gene in resistant house mice in the UK and other European coun-
tries20. A group of linked substitutions Arg12Trp/Ala26Ser/Ala48Thr/Arg61Leu have also been found in mice in 
Germany and Switzerland and are linked to reduced house mouse susceptibility to anticoagulants20. In the UK, 
house mice resistant to the first-generation anticoagulants are widespread and both Leu128Ser and Tyr139Cys 
mutations have been found in the VKORC1 gene of resistant mice13. In France a mutation Trp59Gly in exon 2 of 
the VKORC1 gene was found to be associated with warfarin resistant mice21.
Of the 50 mice samples tested in this study eight (16%, 95% CI: 7.2% to 29.1%) showed no sequence variation 
in the VKORC1 gene in comparison with the Mus musculus VKORC1 reference sequence (NM_178600.2). In 
the remaining 84% (95% CI: 70.9% to 92.8%), one or both of the two point mutations Leu128Ser and Tyr139Cys 
were detected. There was no evidence of the linked substitutions found in mice in Germany and Switzerland or of 
the substitution Trp59Gly found in mice in France. Twenty two mice tested (44%, 95% CI: 30.0% to 58.7%) were 
heterozygous for the point mutation Leu128Ser and 7 (14%, 95% CI: 5.8% to 26.7%) were homozygous (Table 3). 
Sixteen mice (32%, 95% CI: 19.5% to 46.7%) were heterozygous for Tyr139Cys with seven (14%, 95% CI: 5.8% 
to 26.7%) being homozygous. None of the mice tested were homozygous for both Leu128Ser and Tyr139Cys 
mutations.
The occurrence of two mutations associated with resistance to anticoagulants rodenticides is indicative of the 
occurrence of resistance to anticoagulant rodenticides in house mice in at least the Eastern region of the island 
of Ireland. In similar sized European studies resistance was present in >70–80% of tested mice populations22,23. 
This compares well with the values obtained in this study, in which 78% (95% CI: 56.3% to 92.5%) of mice from 
the Dublin region had mutations indicative of resistance (based on n = 23 mice), while for the Eastern region of 
Ireland the value was found to be 84% (95% CI: 70.9% to 92.8%, based on n = 50 mice).
Conclusions
Although the number of samples available for analysis (65) was less than planned, no genetic evidence was found 
of the occurrence and distribution of mutations associated with Norway rat resistance to anticoagulant rodenti-
cides in the Eastern region of Ireland. Having regard to comparable European studies with similar sample num-
bers, the absence of genetic evidence of resistance in the 65 samples taken in the Eastern part of Ireland, suggests 
that there is a high probability that these are true negative findings or that the prevalence is very low.
The data generated confirmed the widespread presence of mutations that result in the two most commonly 
found amino acid substitutions, Leu128Ser and Tyr139Cys, associated with house mice resistance to anticoag-
ulant rodenticides in the Eastern region of Ireland, but these were not present in samples from all counties in 
which samples were collected (see Supplementary Information Table). Of the 6 mutations for which screening 
was conducted (Table 1), only Leu128Ser and Tyr139Cys were detected.
No conclusions can be drawn concerning the occurrence of those mutations in the rest of the island of Ireland. 
Biological testing would be required to establish the extent to which those mutations have conferred field resist-
ance to the house mouse populations concerned, however it is highly likely that such field resistance is present in 
house mouse populations in at least the Eastern Region of Ireland.
The probability remains that field resistance to anticoagulant rodenticides is present in populations of house 
mice in at least the Eastern region of Ireland. The use of anticoagulants in attempts to control rodent pests that 
have developed resistance to them unnecessarily exposes wildlife to poisoning with rodenticides.
Rodent pests are vectors or carry vectors of many serious human and animal diseases, cause significance spoil-
age, losses of food and feed as well as damage to buildings and infrastructure. There are around 200 rodenticide 
products authorised for use in Ireland24, and in excess of 60 companies provide pest control services in Ireland25. 
There is a clear need for further research to establish the extent and distribution of anticoagulant resistance in 
populations of rodent pests on the island of Ireland. Given the challenges identified in collecting sufficient num-
bers of samples from farms, industrial and urban areas on a goodwill basis, it is recommended that any future 
study be funded such that relevant voluntary organisation personnel can be trained in both sample collection and 
handling under the supervision of a PhD student selected to lead the project. Since a key goal of acquiring such 
information is to allow assessment of the extent of resistant populations of rodents and consequently of the extent 
of unnecessary exposure of non-target wildlife to rodenticides though both primary and secondary poisoning, 
the preferred approach is to utilise samples acquired along rural to urban gradients as per the initial strategy 
utilised in this study.
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